AptarGroup with ticker code (ATR) now have 6 market analysts covering the stock. The analyst consensus now points to a rating of ‘Buy’. The range between the high target price and low target price is between 152 and 110 suggesting an average Analsyt target price of $125.67. Now with the previous closing price of $120.59 this indicates there is a potential upside of 4.2%. The 50 day MA is $115.64 and the 200 day MA is $107.76. The market capitalization for the company is $7,872m. Visit the company website at: https://www.aptar.com
The potential market cap would be $8,204m based on the market consensus.
AptarGroup designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through three segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. The company provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. It also sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. In addition, the company offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company primarily sells its products and services through its own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
The company has a dividend yield of 1.26% with the ex dividend date set at 3-5-2023 (DMY).
Other points of data to note are a P/E ratio of 33.54, revenue per share of 50.8 and a 5.64% return on assets.
